Related Experiment Videos
[Immune system in children with pulmonary tuberculosis]
Problemy Tuberkuleza
|January 1, 1995
Summary
This study in children with intrathoracic tuberculosis found impaired T-cell immunity in many patients. Sodium nucleinate improved T-cell immunity, and persistent biomarkers indicated ongoing disease activity.
Area of Science:
- Immunology
- Pediatric Infectious Diseases
- Mycobacterial Infections
Context:
- Intrathoracic tuberculosis presents unique immunological challenges in pediatric populations.
- Assessing immune status is crucial for managing pediatric tuberculosis.
Purpose:
- To investigate T- and B-cell immunity, antibody levels, M. tuberculosis antigens, and circulating immune complexes (CIC) in children with intrathoracic tuberculosis.
- To evaluate the impact of sodium nucleinate on T-cell immunity.
- To determine the prognostic significance of immunological markers post-chemotherapy.
Summary:
- Subnormal T-cell immunity was observed in 39.5% of 61 children with intrathoracic tuberculosis.
- Lower IgA and elevated IgM levels were noted, while B-lymphocyte counts and IgG were normal.
- More advanced disease correlated with weaker T-cell immunity, and acute tuberculosis showed increased CIC, antibodies, and antigens.
- Sodium nucleinate administration aided T-cell immunity normalization.
- Persistent CIC, antibodies, and antigens 2.5-12 months post-chemotherapy suggested active disease requiring further treatment.
Impact:
- Provides insights into the immunological profile of pediatric intrathoracic tuberculosis.
- Highlights the potential therapeutic role of sodium nucleinate in modulating T-cell immunity.
- Establishes the utility of specific biomarkers for monitoring treatment response and disease activity in pediatric TB.